Speaker

Melissa Bradford-Klug

Chief Financial & Business Officer, NorthSea Therapeutics

Melissa Bradford-Klug, Chief Financial & Business Officer at NorthSea Therapeutics, spoke at Finance & Accounting for Bioscience (Boston, United States of America, 24–25 Sept 2026) in the session “Mastering Capital Allocation: Strategies for Successful Commercialization and Product Launches”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Past appearances

Finance & Accounting for Bioscience
24–25 Sept 2026Boston, United States of America
- PlenaryMastering Capital Allocation: Strategies for Successful Commercialization and Product LaunchesWith Nikita Mody-Patel

More speakers at Finance & Accounting for Bioscience

Maricel Apuli
Chief Accounting Officer, BridgeBio
Maggie Berkeley
Biopharma Sector Leader and Risk Advisory Principal, RSM US LLP
Juan Betanzo
Vice President, Strategic Finance, EyePoint
Kwame Boateng
Independent
Kathleen Borthwick
Chief Financial Officer, Passage Bio
Jen Cadigan
Partner & Life Sciences Lead, CrossCountry Consulting

See all 40 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Melissa Bradford-Klug, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].